DETECTING ADALIMUMAB SERUM LEVEL AND ANTI-DRUG ANTIBODIES - FUTURE TOOL IN MONITORING SPONDYLOARTHRITIS PATIENTS?

被引：1
|
作者：
Deaconu, C. [1 ]
Opris, D. [1 ,2 ]
Mazilu, D. [1 ,2 ]
Borangiu, A. [1 ,2 ]
Groseanu, L. [1 ,2 ]
Negru, M. [1 ,2 ]
Constantinescu, C. [1 ,2 ]
Saulescu, I. [1 ,2 ]
Bojinca, V. [1 ,2 ]
Vlad, V. [1 ]
Balanescu, A. [1 ,2 ]
Predeteanu, D. [1 ,2 ]
Ionescu, R. [1 ,2 ]
机构：
[1] SfantaMaria Clin Hosp, Dept Rheumatol & Internal Med, Bucharest, Romania
[2] Univ Med & Pharm Carol Davila, Bucharest, Romania
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-209124.178
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10.06
引用
收藏
页码：A75 / A75
页数：1
相关论文
共 50 条
  • [21] Biologic Therapeutic Drug Monitoring (TDM) of Infliximab and Adalimumab: Serial Monitoring and Distribution of Drug and Anti-Drug Antibodies in 125,950 Patient Samples
    Yang, Jane
    Chun, Kelly
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S946 - S946
  • [22] Therapeutic Drug Monitoring of Infliximab and Adalimumab through Concentration and Anti-Drug Antibodies Assessment; Comparison of Sanquin Diagnostics and Theradiag Assays
    Vroemen, Wim H. M.
    Agata, Shakira S.
    van Beers, Joyce J. B. C.
    Damoiseaux, Jan G. M. C.
    ANTIBODIES, 2024, 13 (03)
  • [23] Disappearance of anti-drug antibodies to infliximab and adalimumab after addition of an immunomodulator in patients with inflammatory bowel disease
    Strik, A.
    van den Brink, G.
    Ponsioen, C.
    Mathot, R.
    Lowenberg, M.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S69 - S70
  • [24] Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial
    Atalay, Selma
    Berends, Sophie E.
    Groenewoud, Hans M. M.
    Mathot, Ron A. A.
    Njoo, David M.
    Mommers, Johannes M.
    Ossenkoppele, Paul M.
    Koetsier, Marjolein I. A.
    Berends, Maartje A.
    de Vries, Annick
    van de Kerkhof, Peter C. M.
    den Broeder, Alfons A.
    de Jong, Elke M. G. J.
    van den Reek, Juul M. P. A.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) : 2680 - 2684
  • [25] Anti-Drug Antibodies Detected By Competitive ELISA Can Predict Treatment Failure in Patients Taking Adalimumab
    Ogric, Manca
    Zigon, Polona
    Lakota, Katja
    Praprotnik, Sonja
    Drobne, David
    Stabuc, Borut
    Semrl, Snezna Sodin
    Cucnik, Sasa
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [26] Evaluation of Immunoassays for the Detection of Anti-Drug Antibodies Against Infliximab and the Corresponding Drug Levels in Patients with Spondyloarthritis in Clinical Practice
    Von Bremen, Helene
    Gamboa, Lorena Martinez
    Zernicke, Jan
    Poddubnyy, Denis
    Feist, Eugen
    AKTUELLE RHEUMATOLOGIE, 2021, 46 (05) : 465 - 473
  • [27] Anti-drug Antibodies Monitoring in Biologics Use: Clinical Implications
    Dhahri, Rim
    Athimni, Selma
    Slouma, Maroua
    Metoui, Leila
    Gharsallah, Imene
    Louzir, Bassem
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2021, 16 (03) : 235 - 238
  • [28] Risk factors for the development of anti-drug antibodies to infliximab and adalimumab in Crohn's disease
    Khoo, E.
    Lord, A.
    Hanigan, K.
    Croft, A.
    Radford-Smith, G.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S378 - S379
  • [29] Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab
    Gorovits, B.
    Baltrukonis, D. J.
    Bhattacharya, I
    Birchler, M. A.
    Finco, D.
    Sikkema, D.
    Vincent, M. S.
    Lula, S.
    Marshall, L.
    Hickling, T. P.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 192 (03): : 348 - 365
  • [30] Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis
    Mori, Ayano
    Saito, Toshiharu
    Takahashi, Miho
    Shibata, Miho
    Tsuji, Goh
    Hatachi, Saori
    Takahashi, Soshi
    Kumagai, Shunichi
    PLOS ONE, 2020, 15 (12):
12345